CSL Behring

RHOPHYLAC

Manufacturer:

CSL Behring

Rhophylac HCPCS:

J2791

HCPCS Code Descriptor:

Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu

Category:

J Code

Rhophylac NDCs:

44206-0300-10, 44206-0300-01

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

44206-0300-10, 44206-0300-01

About Rhophylac:

RHOPHYLAC is an Immunology drug manufactured by CSL Behring and administered via the Injection route of administration. The J Code: J2791 is aligned to the drug RHOPHYLAC.

ACCESS PRICING AND MORE BY REGISTERING

J2791 Added Date:

January 1, 2008

J2791 Effective Date:

January 1, 2016

J2791 Termination Date:

HCPCS Active

Rhophylac billing and coding information can be found through Csl Behring at the link below:
Our team did not identify a source for Rhophylac patient assistance information. Please reach out to our team if you feel that this is a mistake.
RHOPHYLAC prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for RHOPHYLAC. Please check back in a few weeks.